What to Expect From Pfizer, Biogen and Allergan Earnings Tuesday Morning
These three health care companies included are expected to report their earnings on Tuesday morning.
Health and Healthcare
All Health and Healthcare Articles
Newest first · Page 73
12 Stocks Surging That Could Help Treat or Fight Coronavirus
As with almost all pandemic scares and other national and global issues, some speculative stocks manage to see their shares rise sharply.
Pot Grower Aphria Gets C$100 Million Strategic Investment
Canada-based marijuana grower Aphria announced Friday morning a strategic investment of C$100 million. The stock is getting beaten up based on a discount of around 6% to Thursday's closing price for the stock.
How Earnings Will Dictate Biotech Sector’s Fate in 2020
Why Credit Suisse believes that this round of quarterly biotech earnings could prove to be a catalyst for 2020.
This Biotech Could Make a Big Splash With the Coronavirus Scare
New research shows that several members of the coronavirus family are susceptible to inactivation via a system developed by biomedical products company Cerus.
Are Investors Overreacting to This Achromatopsia Study?
Applied Genetic Technologies' shares were crushed early on Thursday after the firm reported interim data from its midstage trial in patients with achromatopsia.
Why This Cardiovascular Disease Study Could Be Huge
Akcea Therapeutics and Ionis Pharmaceuticals each made handy gains on Wednesday after the firms reported midstage results for their cardiovascular disease study.
Some Great News for Potential Alzheimer’s Treatment
Neurotrope released a corporate update after analyzing data from its recently reported Phase 2 confirmatory clinical trial examining moderately severe to severe Alzheimer's disease patients.
Why Johnson & Johnson Stock Is Not Reacting More Positively to Earnings
Health care giant Johnson & Johnson reported fourth-quarter and full-year 2019 results Wednesday morning. The company posted narrow beats and investors have reacted coolly to guidance.
China’s Coronavirus Could Prompt Buying Frenzy in These Biotech Stocks
China is facing an outbreak of the coronavirus, which may have spread to a few other countries in Asia. As a result, experimental vaccine stocks are skyrocketing.
FDA Fast Track on Lung Cancer Treatment Brings Exponential Gains for This Microcap Stock
When companies see their shares rise by 100% or more in a single day, it's usually because of a buyout or an extremely positive change in a company's future prospects. For Genprex, it was…
Winning Ideas in Biotech/Pharma After JPMorgan Healthcare Conference
For health care investors, 2020 looks like a potentially good year after an especially fruitful JPMorgan Healthcare Conference this past week.
China Virus: A Black Swan?
Rarely does a disease spread fast enough and is labeled dangerous enough that it quickly gets the attention of the WHO. A coronavirus, which has killed several people in China and has spread to…
This Week’s Biggest Biotech Movers
This past week played host to a huge number of biotech movers. 24/7 Wall St. has picked a few of these standouts to highlight.
What’s Next for Durect After FDA Posimir Vote
Durect shares dropped early on Friday after an FDA committee vote on Posimir, the company’s pain relief treatment.